Telome Health, Inc. founded in 2010, is dedicated to leveraging the predictive power of telomere science to assess health status, disease risk, and responses to specific therapies. Telome Health's team of expert academic and industrial leaders are applying this Nobel Prize-winning science to market diagnostic and health monitoring tools that will universally benefit human health.
Telome Health was founded by a team of telomere, genomics, and clinical experts whose discoveries founded and remain at the forefront of telomere science, including the 2009 Nobel Laureate in Medicine, Dr. Elizabeth Blackburn, and Drs. Calvin Harley, Elissa Epel, and Jue Lin. Telome Health's founders bring over 90 years' combined experience in telomere science to bear on the company's cutting-edge work developing and delivering diagnostic and health monitoring data. Our company is actively pursuing the research and development of telomere science to assess health status, disease risk, and responses to specific therapies.
Drew Watson is currently a Scientific Advisor to Telome Health along with Dr. Elizabeth Blackburn, Dr. Calvin Harley, Dr. Elissa Eppel, Dr. Jue Lin and Dr. Richard Cawthon. The field of telomere biology holds great promise for near-term advances in the science and delivery of more effective healthcare. Telome Health, Inc. is dedicated to bringing new, practical applications to market: unlocking the aging process associated between our cells and ourselves.